| Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day, D Erritzoe, M Kaelen, ... The Lancet Psychiatry 3 (7), 619-627, 2016 | 1538 | 2016 |
| Psilocybin with psychological support for treatment-resistant depression: six-month follow-up RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ... Psychopharmacology 235, 399-408, 2018 | 917 | 2018 |
| Single-dose psilocybin for a treatment-resistant episode of major depression GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ... New England Journal of Medicine 387 (18), 1637-1648, 2022 | 457 | 2022 |
| Psychiatry & the psychedelic drugs. Past, present & future JJH Rucker, J Iliff, DJ Nutt Neuropharmacology 142, 200-218, 2018 | 363 | 2018 |
| Psychedelics in the treatment of unipolar mood disorders: a systematic review JJH Rucker, LA Jelen, S Flynn, KD Frowde, AH Young Journal of Psychopharmacology 30 (12), 1220-1229, 2016 | 201 | 2016 |
| Male-biased autosomal effect of 16p13. 11 copy number variation in neurodevelopmental disorders M Tropeano, JW Ahn, RJB Dobson, G Breen, J Rucker, A Dixit, DK Pal, ... PloS one 8 (4), e61365, 2013 | 145 | 2013 |
| Psychedelics, mystical experience, and therapeutic efficacy: a systematic review K Ko, G Knight, JJ Rucker, AJ Cleare Frontiers in psychiatry 13, 917199, 2022 | 116 | 2022 |
| Depressive disorder moderates the effect of the FTO gene on body mass index M Rivera, S Cohen-Woods, K Kapur, G Breen, MY Ng, AW Butler, ... Molecular psychiatry 17 (6), 604-611, 2012 | 107 | 2012 |
| Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes A Noor, AC Lionel, S Cohen‐Woods, N Moghimi, J Rucker, A Fennell, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014 | 89 | 2014 |
| Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals M Rivera, AE Locke, T Corre, D Czamara, C Wolf, A Ching-Lopez, ... The British Journal of Psychiatry 211 (2), 70-76, 2017 | 78 | 2017 |
| Genome-wide association analysis of copy number variation in recurrent depressive disorder JJH Rucker, G Breen, D Pinto, I Pedroso, CM Lewis, S Cohen-Woods, ... Molecular psychiatry 18 (2), 183-189, 2013 | 70 | 2013 |
| The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous … JJ Rucker, L Marwood, RLJ Ajantaival, C Bird, H Eriksson, J Harrison, ... Journal of psychopharmacology 36 (1), 114-125, 2022 | 67 | 2022 |
| OPCRIT+: an electronic system for psychiatric diagnosis and data collection in clinical and research settings J Rucker, S Newman, J Gray, C Gunasinghe, M Broadbent, P Brittain, ... The British Journal of Psychiatry 199 (2), 151-155, 2011 | 64 | 2011 |
| Psilocybin and MDMA for the treatment of trauma-related psychopathology CIV Bird, NL Modlin, JJH Rucker International Review of Psychiatry 33 (3), 229-249, 2021 | 59 | 2021 |
| Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis K Ko, EI Kopra, AJ Cleare, JJ Rucker Journal of Affective Disorders 322, 194-204, 2023 | 54 | 2023 |
| Association of copy number variation of the 15q11. 2 BP1-BP2 region with cortical and subcortical morphology and cognition D Van Der Meer, IE Sønderby, T Kaufmann, GB Walters, A Abdellaoui, ... JAMA psychiatry 77 (4), 420-430, 2020 | 53 | 2020 |
| Dose response of the 16p11. 2 distal copy number variant on intracranial volume and basal ganglia IE Sønderby, Ó Gústafsson, NT Doan, DP Hibar, S Martin-Brevet, ... Molecular psychiatry 25 (3), 584-602, 2020 | 53 | 2020 |
| Mental capacity and psychiatric in-patients: implications for the new mental health law in England and Wales GS Owen, G Szmukler, G Richardson, AS David, P Hayward, J Rucker, ... The British Journal of Psychiatry 195 (3), 257-263, 2009 | 53 | 2009 |
| International online survey of 1048 individuals with functional neurological disorder M Butler, O Shipston‐Sharman, M Seynaeve, J Bao, S Pick, ... European Journal of Neurology 28 (11), 3591-3602, 2021 | 52 | 2021 |
| Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential JJH Rucker Bmj 350, 2015 | 48 | 2015 |
